Myomo
MYO • AMEX
Myomo is a medical - devices company in the healthcare sector trading on AMEX, led by CEO Paul R. Gudonis, with a market cap of $26.8M.
CEOPaul R. Gudonis
Next Earnings
Upcoming earnings announcement for Myomo
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Revenue Estimate
$9.3M
Earnings History
Past 12 earnings reports for Myomo
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.09Est: -$0.09 | 0.0% | $11.4MEst: $10.3M | +10.2% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.09Est: -$0.11 | +18.2% | $10.1MEst: $9.4M | +7.6% | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.11Est: -$0.11 | 0.0% | $9.7MEst: $9.1M | +5.9% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.08Est: -$0.08 | 0.0% | $9.8MEst: $9.2M | +6.6% | 10-Q |
| Mar 10, 2025 | Q4 2024 | -$0.01Est: -$0.02 | +50.0% | $12.1MEst: $9.9M | +21.9% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.03Est: -$0.04 | +25.0% | $9.2MEst: $8.1M | +13.5% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.03Est: -$0.09 | +66.7% | $7.5MEst: $5.3M | +41.4% | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.10Est: -$0.10 | 0.0% | $3.8MEst: $4.1M | -7.8% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.07Est: -$0.06 | -16.7% | $4.8MEst: $4.8M | -0.7% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.06Est: -$0.09 | +33.3% | $5.1MEst: $4.2M | +22.4% | — |
| Aug 9, 2023 | Q2 2023 | -$0.04Est: -$0.03 | -33.3% | $6.0MEst: $5.6M | +5.8% | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.11Est: -$0.13 | +15.4% | $3.4MEst: $3.3M | +3.5% | — |